Navigation Links
Teva's Forum Draws Key Pennsylvania Healthcare Leaders
Date:7/30/2009

State Influentials Gather to Discuss the Rising Cost of Medicine for Consumers

PHILADELPHIA, July 30 /PRNewswire-USNewswire/ -- Teva Pharmaceuticals USA, the world's leading generic pharmaceutical company, today hosted the last in a series of roundtable discussions focused on increasing access to healthcare and affordable medicines in the United States.

The event was held as a part of the company's Year of Affordable Healthcare Campaign (www.yearofaffordablehealth.com), which marks the 25th anniversary of the passing of the Hatch-Waxman Act, a bill which created the modern day pharmaceutical drug industry.

The event featured panelists from around the Philadelphia area, all of whom have distinguished themselves by helping to bring affordable healthcare solutions to the people of Pennsylvania. They included:

  • Thomas Snedden, Director, Pennsylvania Pharmaceutical Assistance Contract for the Elderly
  • Pat Halpin-Murphy, President and Founder, Pennsylvania Breast Cancer Coalition
  • Dr. Janet Young, Medical Director, Greater Philadelphia Health Action, Inc.
  • Donna Duncan, Executive Director, Philadelphia's Linda Creed Breast Cancer Foundation

The panel was moderated by Pam Gilbert, partner at Cuneo Gilbert & LaDuca and former executive director of the Consumer Product Safety Commission.

"We are now at a crucial point in this debate," said Debra Barrett, Senior Vice President of Government Affairs for Teva Pharmaceuticals USA. "Healthcare costs continue to rise and consumers in some cases are struggling to access care. We need to ensure that affordable medicine options like biogenerics are available, so that Pennsylvania citizens don't have to worry about being able to afford their prescriptions."

The spirited discussion centered around the need for healthcare reform, the steadily increasing costs of medicines and treatments and potential solutions for these rising costs -- including the development of a pathway for generic biologic medicines.

About Teva USA

Teva Pharmaceutical Industries Ltd., headquartered in Israel, is among the top 20 pharmaceutical companies in the world and is the world's leading generic pharmaceutical company. The Company develops, manufactures and markets generic and innovative human pharmaceuticals and active pharmaceutical ingredients, as well as animal health pharmaceutical products. Over 80 percent of Teva's sales are in North America and Europe.


'/>"/>
SOURCE Teva Pharmaceuticals USA
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. MedHelp to Add Top Stanford Surgeons and Specialized Forums to Online Health Community
2. Neusoft Becomes First Global Growth Company Partner of World Economic Forum
3. Exponent to Present at the Upcoming Sidoti & Company Investor Forum and William Blair Small-Cap Growth Stock Conference
4. Hooper Holmes Launches Health & Wellness Division at 2007 Disease Management Leadership Forum and Integrated Care Summit
5. Blue Cross and Blue Shield Association Holds Forum to Explore Patient Safety and Healthcare Quality Initiatives
6. Sponsor of Presidential Health Care Forum Has a $4 Billion Conflict of Interest: Kucinich
7. National Quality Forum Issues First Consensus Standards for the Treatment of Substance Use Conditions
8. National Quality Forum Announces New Member Councils Leadership
9. American Society of Transplantations Past President Testifies Before Congress at Forum on Organ Donation
10. Transcept Pharmaceuticals, Inc. to Present at 2007 BIO Investor Forum
11. SGX Pharmaceuticals to Present at the BIO InvestorForum 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... Alert Sentry Group LLC., a ... Personal Emergency Response Systems), the iSAFE and the iSAFE Plus. These iSAFE products are ... of their kind, the iSAFE and iSAFE Plus offer direct GPS Location and two-way ...
(Date:3/28/2017)... ... March 28, 2017 , ... Calibration, ... to ensuring high-quality results and maintaining GMP and USP compliance. In a new ... accordance with GMP requirements " these requirements are explained. The challenge is ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... measurement of corrosive ions found in power plant water and steam. , Chlorides ... as turbines and boilers, leading to extensive maintenance and unplanned shutdowns. Monitoring these ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... offered by the American Association of Integrative Medicine and available for application on ... at the AutismOne 2017 Conference in Colorado Springs. , Ed Arranga, president of ...
(Date:3/28/2017)... ... March 28, 2017 , ... Silicon Valley Hair Institute, the San Francisco ... blog post about women’s hair loss. Although hair transplant procedures can be seen as ... Menopause or genetics can be two reasons a woman may see her hair thinning. ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... LONDON , March 27, 2017 ... require to better understand Eli Lilly and its partnering interests ... Alliance since 2010 report provides an in-depth insight into the ... companies. On demand company reports are prepared upon ... deal and company data. The report will be ...
(Date:3/27/2017)... VANCOUVER, British Columbia , March 27, 2017 /PRNewswire/ ... of Directors has appointed William "Bill" Dubiel as President ... Dubiel was also elected to the Board of Directors ... serve as the Executive Chairman of LightIntegra. ... become LightIntegra,s next President and Chief Executive Officer. We,ve ...
(Date:3/27/2017)... and VANCOUVER, British Columbia, March 27, 2017 /PRNewswire/ ... (the "Company" or "Sophiris"), a clinical late-stage biopharmaceutical ... patients with urological diseases, today reported fourth quarter ... corporate highlights. Key Corporate Highlights: ... Development for Localized Prostate Cancer. During 2016, the ...
Breaking Medicine Technology: